Nutriband Inc. (NASDAQ:NTRB - Get Free Report)'s share price dropped 8.1% on Tuesday . The company traded as low as $5.52 and last traded at $5.82. Approximately 18,083 shares changed hands during mid-day trading, a decline of 51% from the average daily volume of 36,552 shares. The stock had previously closed at $6.33.
Nutriband Trading Up 2.6 %
The company has a quick ratio of 6.36, a current ratio of 6.57 and a debt-to-equity ratio of 0.01. The company has a market capitalization of $65.88 million, a P/E ratio of -7.75 and a beta of 1.12. The firm's 50-day moving average price is $5.69 and its 200 day moving average price is $5.39.
Nutriband (NASDAQ:NTRB - Get Free Report) last posted its earnings results on Tuesday, September 3rd. The company reported ($0.12) earnings per share for the quarter. Nutriband had a negative net margin of 401.39% and a negative return on equity of 66.60%. The company had revenue of $0.44 million during the quarter.
Institutional Trading of Nutriband
An institutional investor recently bought a new position in Nutriband stock. Virtu Financial LLC bought a new position in shares of Nutriband Inc. (NASDAQ:NTRB - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 12,862 shares of the company's stock, valued at approximately $58,000. Virtu Financial LLC owned approximately 0.12% of Nutriband as of its most recent SEC filing. Institutional investors and hedge funds own 19.70% of the company's stock.
Nutriband Company Profile
(
Get Free Report)
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Featured Articles
Before you consider Nutriband, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutriband wasn't on the list.
While Nutriband currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
